Skip to content

Side by side

L-Carnitine vs Tirzepatide

Both are discussed for weight loss. What this site records about each, side by side. Every figure is on the compound's own page with the source it came from.

L-Carnitine and Tirzepatide compared on what BioAlmanac records.
 L-CarnitineTirzepatide
What it isAn essential cofactor for burning fat, and not the step that limits it. Approved for genuine carnitine deficiency; sold by injection for weight loss on weak evidence.A once-weekly dual agonist that activates both the GIP and GLP-1 receptors, approved for type 2 diabetes and for weight management.
EvidenceHow much human evidence exists, not how well it works.ApprovedApproved
Regulatory statusReviewed 2026-08-18Levocarnitine is an FDA-approved prescription medicine for primary and secondary carnitine deficiency. Oral carnitine is also sold as a dietary supplement. Injectable carnitine for weight loss is not an approved use.Approved by the FDA as a prescription medicine for type 2 diabetes and for chronic weight management. Material sold as a research chemical is not the approved product and is not legal to sell for human use.
RoutesOral, Intramuscular, IntravenousSubcutaneous
Half-life17.4 hours120 hours
Cheapest per mgVials only, read from vendors' own listings and dated on the price index.$0.01/mg$1.00/mg
Median per mg$0.08/mg$3.17/mg
Vendors with a price1333
Storage once mixedInjectable carnitine is supplied as a solution, not a powder.Refrigerated at 2–8 °C. Do not freeze. Discard if cloudy or discoloured.

Compare two other compounds · The full price index

This page is educational. It describes what published research reports, not what you should do. Peptides discussed here are largely not approved for human use, and nothing on BioAlmanac is medical advice. Nothing here ranks these two against each other. A table can show that one has more human evidence behind it or costs less per milligram; neither of those is a recommendation, and the right comparison for any person is one their doctor makes with them.